CHINA LIFE INSURANCE CO-ADR (LFC)

US16939P1066 - ADR

7.05  -0.06 (-0.84%)

After market: 6.92 -0.13 (-1.84%)

Fundamental Rating

2

Taking everything into account, LFC scores 2 out of 10 in our fundamental rating. LFC was compared to 141 industry peers in the Insurance industry. LFC may be in some trouble as it scores bad on both profitability and health. LFC is valied quite expensively at the moment, while it does show a decent growth rate.



Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year LFC was profitable.
Each year in the past 5 years LFC has been profitable.
In the past 5 years LFC always reported a positive cash flow from operatings.

1.2 Ratios

Industry RankSector Rank
ROA 0.68%
ROE 7.37%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LFC does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 4.24%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

LFC does not have a ROIC to compare to the WACC, probably because it is not profitable.
LFC has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for LFC has been reduced compared to a year ago.

2.2 Solvency

LFC has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC7.09%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 139.52% over the past year.
LFC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.18% yearly.
The Revenue for LFC has decreased by -32.60% in the past year. This is quite bad
The Revenue has been growing by 9.32% on average over the past years. This is quite good.
EPS 1Y (TTM)139.52%
EPS 3Y66.55%
EPS 5Y12.18%
EPS growth Q2Q230.88%
Revenue 1Y (TTM)-32.6%
Revenue growth 3Y10.07%
Revenue growth 5Y9.32%
Revenue growth Q2Q-66.61%

3.2 Future

Based on estimates for the next years, LFC will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.07% on average per year.
The Revenue is expected to grow by 5.44% on average over the next years.
EPS Next Y-4.25%
EPS Next 2Y8.44%
EPS Next 3Y9.31%
EPS Next 5Y12.07%
Revenue Next Year-3.3%
Revenue Next 2Y1.25%
Revenue Next 3Y4.1%
Revenue Next 5Y5.44%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 1.90, the valuation of LFC can be described as very cheap.
When comparing the Price/Earnings ratio of LFC to the average of the S&P500 Index (25.02), we can say LFC is valued rather cheaply.
A Price/Forward Earnings ratio of 4.61 indicates a rather cheap valuation of LFC.
LFC is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.32, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 1.9
Fwd PE 4.61

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.16
EPS Next 2Y8.44%
EPS Next 3Y9.31%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LFC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHINA LIFE INSURANCE CO-ADR

NYSE:LFC (9/1/2022, 7:19:19 PM)

After market: 6.92 -0.13 (-1.84%)

7.05

-0.06 (-0.84%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap39.85B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 1.9
Fwd PE 4.61
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.16
Profitability
Industry RankSector Rank
ROA 0.68%
ROE 7.37%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 4.24%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)139.52%
EPS 3Y66.55%
EPS 5Y
EPS growth Q2Q
EPS Next Y-4.25%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-32.6%
Revenue growth 3Y10.07%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y